An element used in contrast media for the enhancement of MRIs.
An element used to provide image contrast during MRI scanning, typically held by a carrier, or chelate molecule, called DTPA.
gadolinium is a non-toxic paramagnetic contrast enhancement agent utilized in MR imaging. When injected during the scan, gadolinium will tend to change signal intensities by shortening T1 in its surroundings.
A chemical compound which can be administered to a person, having MRI imaging done, to enhance the distinction between new lesions and old lesions.
A contrast material given at the time of MRI which concentrates in the tumor and makes it more visible
A chemical compound that can be administered to a person during MRI (magnetic resonance imaging) to help distinguish between new lesions and old lesions in the C NS (Central nervous system).
a chemical compound given during MRI scans that helps distinguish new lesions from old.
A contrast agent that is given intravenously during MRI (magnetic resonance imaging) to increase visualization of specific abnormalities.
DTPA, Gadolinium-DTPA-BMA, Gadolinium-DOTA, Gadolinium-DO3A, Gadolinium-BOPTA, and similar — Paramagnetic; see also List of Contrast Agents in FAQ.
a type of contrast agent used during MRI.
A contrast agent sometimes intravenously administered during MRI exams to increase the visibility of body tissue in the MRI images.